Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Doxycycline for Macrolide-Resistant Mycoplasma Pneumoniae Pneumonia in Children Under 8 Years
ChiCTR2500110950Phase 4Not yet recruiting
- Sponsor
- Affiliated Suzhou Hospital of Nanjing Medical University
- Start
- Oct 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of doxycycline in Mycoplasmal pneumonia, sponsored by Affiliated Suzhou Hospital of Nanjing Medical University. Primary endpoints: Plasma concentration of doxycycline, Body temperature and 3 more. Planned start Oct 2025; status: not yet recruiting.
02
Drugs
doxycycline
03
Conditions
Mycoplasmal pneumonia
Beyond the preview
Go deeper on ChiCTR2500110950.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2500110950.